KLOW™ is a multi-peptide formulation combining BPC-157, TB-500, GHK-Cu, and KPV. The blend is designed to support tissue recovery, skin health, and the body's natural healing processes by bringing together peptides with complementary roles in preclinical research. It is commonly marketed for recovery, connective tissue support, and skin rejuvenation.
KLOW™ is an advanced peptide blend formulated with BPC-157 (10 mg), TB-500 (10 mg), GHK-Cu (50 mg), and KPV (10 mg). Each peptide has been investigated for different biological activities, and the combination is intended to provide broad support for tissue repair and recovery.
BPC-157 has been studied for its potential role in supporting the healing of muscles, tendons, ligaments, and the gastrointestinal lining.
TB-500 is a synthetic fragment related to thymosin beta-4 and has been researched for its involvement in cell migration, tissue repair, and recovery following injury.
GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding peptide that has been studied for promoting collagen production, supporting skin repair, improving skin appearance, and contributing to scalp and hair health.
KPV is a short peptide derived from alpha-MSH that has demonstrated anti-inflammatory activity in laboratory and animal studies, particularly in skin and gastrointestinal research.
Together, these peptides are intended to support:
Important: KLOW™ is not an approved medication for these uses. Evidence for many peptide therapies is still emerging, and most proposed benefits are based on laboratory, animal, or limited human studies. It should not be marketed with claims of treating, curing, or preventing disease, and any use should be under appropriate medical guidance where applicable.
High-quality research-grade peptides and compounds engineered for scientific innovation and laboratory use.